Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosisXiaobing Wang, Huji Xu, Yi Xiao et al.|Cell|2024Cited by 272
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosisXiaobing Wang, Huji Xu, Yi Zhang et al.|Cell|2025Cited by 61
Identification of a receptor tyrosine kinase inhibitor CP-724714 inhibits SADS-CoV related swine diarrhea coronaviruses infection in vitroLing Zhou, Jingyun Ma|Virologica Sinica|2023Cited by 5